Brief: SSY Group Obtains NMPA Approval For Fat-Soluble Vitamin Injection
06/05/2026 08:26
May 6 (Reuters) - SSY Group Ltd 2005.HK: OBTAINS NMPA APPROVAL FOR FAT-SOLUBLE VITAMIN INJECTION (10ML), TYPE 3, PASSES CONSISTENCY EVALUATION OBTAINS NMPA APPROVAL FOR DOXAZOSIN MESYLATE EXTENDED RELEASE TABLETS (4MG), TYPE 4, PASSES CONSISTENCY EVALUATION OBTAINS NMPA CHINA APPROVAL FOR METFORMIN HYDROCHLORIDE TABLETS (0.5G, 0.25G), TYPE 4, PASSES CONSISTENCY EVALUATION Further company coverage: 2005.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on SSY
See all newsBrief: SSY Group Receives NMPA China Approval For Sodium Cromoglicate Eye Drops 2%
Brief: SSY Group Obtains NMPA Approval For Nimodipine Oral Solution
Brief: SSY Group Appoints Wu Heng Yao As Executive Director
Brief: SSY Group Says Ziprasidone Mesilate Receives Registration Approval In China
Hong Kong's SSY Group H1 profit rises on infusion solutions growth